-+ 0.00%
-+ 0.00%
-+ 0.00%
German Court Overturns Halozyme Injunction Blocking Merck's Keytruda SC Launch
Share
Listen to the news
German Court Overturns Halozyme Injunction Blocking Merck's Keytruda SC Launch
  • A German appeals court overturned a December 2025 preliminary injunction blocking Merck’s Keytruda SC launch in Germany.
  • Halozyme Therapeutics plans to immediately file a German patent infringement lawsuit against Merck seeking permanent relief.
  • A separate Dutch patent ruling in October 2026 prohibited Merck’s European marketing authorization holder from infringing through Keytruda SC in eight countries.
  • The MDASE patent dispute will not affect ENHANZE licensing rights or revenue, as the patents are distinct.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halozyme Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611190920PR_NEWS_USPR_____LA02628) on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending